Propofol during Cardiopulmonary Bypass in a Patient Susceptible to Malignant Hyperpyrexia
- 1 November 1988
- journal article
- case report
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 16 (4) , 482-485
- https://doi.org/10.1177/0310057x8801600416
Abstract
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.This publication has 15 references indexed in Scilit:
- DIAGNOSIS OF SUSCEPTIBILITY TO MALIGNANT HYPERTHERMIA IN MANBritish Journal of Anaesthesia, 1988
- MALIGNANT HYPERTHERMIA: BIOCHEMICAL ASPECTS OF THE ACUTE EPISODEBritish Journal of Anaesthesia, 1988
- PROPOFOL AND MALIGNANT HYPERPYREXIAThe Lancet, 1988
- Propofol infusion for coronary artery bypass surgery in a patient with suspected malignant hyperpyrexiaAnaesthesia, 1987
- Propofol infusion for sedation in the intensive care unit: preliminary report.BMJ, 1987
- DISPOSITION OF PROPOFOL IN PATIENTS UNDERGOING SURGERYBritish Journal of Anaesthesia, 1986
- The work of the Leeds Malignant Hyperpyrexia Unit, 1971–84Anaesthesia, 1986
- DantroleneCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1984
- Management of a malignant hyperthermia patient during cardiopulmonary bypassCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1982
- Malignant HyperthermiaAnesthesiology, 1980